BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 28, 2005
View Archived Issues
Enrollment under way in phase IV study of Modrenal
Read More
Lomucin studied in phase II trial for cystic fibrosis
Read More
Recombinant vaccine induces an immune response in mice challenged with H9N2 influenza
Read More
CHF-3381 demonstrates in vivo efficacy for pain associated with central sensitization
Read More
BioLineRx receives funding to support development of BL-1020 and others
Read More
U.S. phase III study begins for Miraxion in Huntington's disease
Read More
Anticancer activity observed for Welichem Biotech's WBI-2000 series
Read More
CollaGenex studies incyclinide for acne
Read More
Amrad seeks to change name to Zenyth Therapeutics
Read More
Scios to study nesiritide in acute decompensated heart failure
Read More
CH-1504 for rheumatoid arthritis studied in phase I trials
Read More
Enrollment discontinued in Avastin phase II study in ovarian cancer
Read More
ABHS shows synergy with tPA in a preclinical model of acute ischemic stroke
Read More
Corgentech and AlgoRx to merge
Read More
Recent patents disclose novel analgesic agents
Read More
Rozerem now available
Read More
New therapeutic agents for gastrointestinal disorders revealed
Read More
AstraZeneca submits NDA for Symbicort
Read More
European orphan drug status for Troxatyl in AML
Read More
Antiasthmatic actions of L-97-1 in preclinical tests
Read More
Novel peptide from shark liver exerts antidiabetic effects in mice
Read More
A novel glucokinase activator shows promise as an antidiabetic
Read More
Lipitor approved to reduce risk of strokes and heart attacks in diabetics
Read More
Antidiabetic effect of A2B adenosine receptor antagonism
Read More
New data indicate superior potency of MB-06322 as a treatment for type 2 diabetes
Read More
PPARalpha/gamma agonist improves glucose tolerance without stimulating weight gain and adiposity
Read More
Recent Sumitomo patent covers novel treatments for anxiety and depression
Read More
Supplemental BLA submitted for Tysabri for MS
Read More
Janssen patents novel antimycobacterial agents
Read More
Update on AAE-581 in the management of osteoporosis
Read More
New data supports the use of exenatide in the treatment of type 2 diabetes
Read More
Dacarbazine plus natural IFN alpha improves survival in patients with high-risk cutaneous melanoma
Read More